SLC5A5 and breast cancer: As shown in Table 1, NIS mRNA expression among breast tumors deviated from the mean by less than 12% in two additional datasets utilizing the HG U133 Plus 2.0 platform, confirming that the sensitivity of the 211123_at probe set was too low to detect variability in NIS mRNA levels among breast cancers.